Casandra
Casandra Test Code QD10055Version 1 (DRAFT)
Performing Lab
Flecainide
Clinical Use
Order TestUse
Monitoring the flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Flecainide
AnalyteFlecainide concentration
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
3-6 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
red-top tube (no gel)
Patient Preparation
Optimum time to collect sample: 1 hour before next dose
Causes for Rejection
Gross hemolysis • Lipemia • Gel barrier/serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Similar Tests
Other tests from different labs that may be relevant
Flecainide
ARUP Laboratories
Flecainide, Serum
Mayo Clinic Lab
Flecainide, Serum or Plasma
Labcorp
Propafenone, Serum
Mayo Clinic Lab
Propafenone Quantitation, Serum or Plasma
ARUP Laboratories
Propafenone, Serum or Plasma
Labcorp
Tocainide, Serum or Plasma
Labcorp
Mexiletine, Serum or Plasma
Labcorp
Amiodarone, Serum
Mayo Clinic Lab
Amiodarone (Cordarone), Serum or Plasma
Labcorp